To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children
Clinical trial NCT04618939 · COMPLETED
Trial details
- NCT number
- NCT04618939
- Sponsor
- Boryung Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-20
- Primary completion
- 2017-04-28
- Enrollment
- 218
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.